ESC Premium Access

PR interval prolongation, still a marker of worse outcome in patients treated with cardiac resynchronization therapy

Congress Presentation

About the speaker

Professor Kevin Vernooy

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
25 presentations

8 more presentations in this session

His bundle pacing in patients pacemaker indication and with mildly reduced ejection fraction

Speaker: Mr R. Gardas (Katowice, PL)


Differential effect of CRT in ischemic and non-ischemic cardiomyopathy: longterm follow-up data from a single center cohort study

Speaker: Doctor P. Kahr (Schlieren, CH)


Implant procedure and lead handling characteristics of a novel active fixation quadripolar lead: Results from the Attain Stability Quad clinical trial

Speaker: Professor S. Faerestrand (Bergen, NO)


Cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy and severe heart failure may influence the development of unstable ventricular tachycardia

Speaker: Doctor D. Lebedev (Kemerovo, RU)


Atrioventricular optimization in cardiac resynchronization therapy with quadripolarleads, improves energy handling and quality of life in heart failure patients: HUMVEE Trial

Speaker: Doctor C. Antoniou (Athens, GR)


Access the full session

Poster Session 5 - Heart failure devices: new approaches

Speakers: Professor K. Vernooy, Mr R. Gardas, Doctor P. Kahr, Professor S. Faerestrand, Doctor D. Lebedev...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb